30
06 '21
My research team recently started a highly intensive research study this week: an investigational drug in phase 3 of clinical trials (the last stage before FDA approval) is given over 12 consecutive days. Day 1 involves nine busy hours of study tasks, including a 4-hour mixed-meal tolerance test, insulin and glucose review, safety labs, infusion…